What is CJC-1295
CJC-1295 is a long-acting Growth Hormone Releasing Hormone (GHRH) analog designed to extend half-life and support sustained GH and IGF-1 secretion in experimental models.
Potential Research Effects
• Prolonged growth hormone release and increased IGF-1
• Enhanced lean muscle mass and recovery
• Improved sleep quality and tissue repair
• Support for lipid metabolism and energy regulation
Includes 10 sterile research-use syringes with every vial order.
Cybergen Peptides: Research Use Disclaimer
All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes.
These materials are supplied for in-vitro research only (“in glass”) and are
not intended for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have
not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency.
They are not intended to diagnose, treat, cure, or prevent any disease.
Any form of bodily introduction, clinical testing, or therapeutic application is strictly prohibited.
